Loss of Tau Induces Age-Dependent Anaemia with Reduced Longevity in Mice
Peng Lei,Scott Ayton,Ambili Thoppuvalappil Appukuttan,David Finkelstein,Ashley Bush
DOI: https://doi.org/10.1016/j.jalz.2013.05.1424
2013-01-01
Abstract:Tau protein is pathologically involved in Alzheimer's disease (AD) and Parkinson's disease. However neither the function of tau nor the precise mechanism of tau toxicity is known. We, and others, recently reported that aged-tau knockout mice exhibit behavioural deficits. We showed that these mice exhibit neurodegeneration that is pharmacologically linked with brain iron dysregulation. Tau protein is mainly expressed in the brain, but it is also found in peripheral organs such as blood, heart and kidney. Here we report a survey of peripheral organs in tau knockout to determine the peripheral function of tau and potential implications for its loss of function in peripheral diseases. Tau knockout mice (tau KO) and background C57BL6/SV129 control mice (WT), at 6 and 12 months of age (n=10 per group, containing both males and females), were weighed before being sacrificed for biochemical studies and full blood examination. Full blood examination was performed by Gribbles Veterinary Pathology (Clinical Laboratories Pty Ltd, Melbourne). As previously reported, the average wet brain weight of 12-months old tau KOs was significantly reduced (-13%, p<0.001) compared to WT, although the body weights remain unaltered. Full blood examination indicated impairment of kidney function in tau KOs from 6 months old, evidenced by significant alterations in sodium, potassium, chloride, bicarbonate, Na/K ratio, and urea levels in the blood. Compared to WT mice at 12-months, tau KO also exhibited cardiomegaly (+20%, p =0.044). 6-months old tau KOs were microcytic (-4% MCV, p =0.002) which developed into anaemia at 12 months of age, evidenced by significantly reduced haemoglobin levels (-10%, p =0.03) and other marked changes to haematological profile. These changes might be upstream of reduced longevity of tau KOs (mean survival WT=22.8, KO=20.9; n(WT=44), n(KO)=64; p =0.0025). Here we report that, in additional to impaired brain iron homeostasis and neurodegeneration, loss of tau also causes reduced lifespan accompanying peripheral abnormalities such as anaemia, cardiomegaly and kidney dysfunction, further supporting our hypothesis that tau plays a crucial role in iron homeostasis and age-related diseases. Loss-of-tau function may also contribute to tau toxicity in AD, and therapies to reduce tau need to be carefully evaluated.